You are here

Mediar Therapeutics

Eli Lilly pushes into pulmonary fibrosis with $99M deal for Mediar's midphase prospect

Fierce Biotech

Fri, 01/10/25 - 11:39 am

idiopathic pulmonary fibrosis

Mediar Therapeutics

Mediar gets a spark from Pfizer’s Ignite scheme as lead fibrosis programs progress

Fierce Biotech

Wed, 10/25/23 - 10:49 pm

Mediar Therapeutics

Novartis and Pfizer-Backed Mediar Nets $85M for Fibrosis Paradigm Shift

BioSpace

Wed, 03/15/23 - 11:17 am

Mediar Therapeutics